The splice variants of vascular endothelial growth factor (VEGF) and their receptors
about
sameAs
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signalingEMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGFA mechanosensitive transcriptional mechanism that controls angiogenesisHeparan sulphate synthetic and editing enzymes in ovarian cancerProcessing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumorsThe vascular endothelial growth factor (VEGF) family: angiogenic factors in health and diseaseThe mRNA expression of hTERT in human breast carcinomas correlates with VEGF expressionHigh-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometryAngiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal MedicineThe cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysisBrain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mindUnexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor functionEndometriosis, angiogenesis and tissue factor3D multi-cell simulation of tumor growth and angiogenesisCanonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cordStructural determinants of growth factor binding and specificity by VEGF receptor 2SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular diseaseWT1-dependent sulfatase expression maintains the normal glomerular filtration barrierSoluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survivalEffect of antiprogesterone RU486 on VEGF expression and blood vessel remodeling on ovarian follicles before ovulationMetabolic impact of anti-angiogenic agents on U87 glioma cellsThe related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cellsTotal Internal Reflection with Fluorescence Correlation Spectroscopy: Nonfluorescent CompetitorsVascular endothelial growth factor (VEGF) regulates cranial neural crest migration in vivo.Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy.The mutual impact of syndecan-1 and its glycosaminoglycan chains--a multivariable puzzle.Construction and expression of a lentivirus expression vector carrying the VEGF165-EGFP fusion gene in breast cancer MCF-7 cells.Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.Opioids: Modulators of angiogenesis in wound healing and cancer.Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancerVEGF receptor expression decreases during lung development in congenital diaphragmatic hernia induced by nitrofenThe VEGF family in cancer and antibody-based strategies for their inhibition.Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.Reduced vascular endothelial growth factor expression in contusive spinal cord injury.Systemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment.
P2860
Q24296700-3E68A6D0-4B50-4A9D-9701-EA90E4B9B587Q24310236-FD2DE737-8655-4726-A3AA-5A16E440136DQ24314809-AA1763EA-35AC-4D57-9AE8-23C0F6126288Q24653774-9400A1A1-A09D-4F2A-A65A-C54EAB81CB80Q24678647-C5093855-1C63-4277-866A-8AC573C927DEQ24796165-E47FF228-7043-40D7-8B70-8A096A456483Q24797652-0A29DE7C-0839-44DB-A2C2-3E30045A9CA9Q24810619-C10D5D23-ACCC-407C-BBEC-7D962D03179AQ26747497-A4C13399-32EC-41B8-A404-A3D5B4B296FCQ26796921-4D0497F6-E813-4929-9B16-AC23D69A8001Q26826870-FBE3C8BD-5F9D-4BDF-8208-A4C469B70CFFQ27000674-076BFC86-A609-4851-A889-B85131B4C05DQ27013803-3909BB2F-7422-4D98-8119-3EE3049366AFQ27340441-0B1A2E6C-3AFD-4DEF-AC97-409C8DB63750Q27342723-DE652DB2-FD92-4B91-B6A9-BAC85B2F2DE5Q27438174-9C37E639-C2F0-442D-B6C2-25E71464DC17Q27659686-313C97DB-25E9-4231-A84F-D1914E096EF8Q28066121-8D0497C2-4699-42FF-B804-8B1819EBE83FQ28506573-3D492BC7-9AA9-4D1B-A52B-84F222CEE8A0Q28511090-5D051E99-D49E-42A1-9814-87B26C551722Q28538130-F8EB34F1-368A-4625-9C7D-E1A5A0B90A24Q28539644-4554D7C4-BFAD-4E1A-8542-5D0416FD6F7EQ28728051-992D6601-C936-4823-98C8-3CDDD6B38E22Q29304399-4A9A7747-8C7D-4289-98FF-40EEC524A3F8Q30528379-BAB072F7-25DC-44D5-8A64-D3DF835B0DBCQ30568524-1B61E38C-AC19-4BAE-9AC2-B14016C98DF4Q33258465-0832BC0F-2497-4122-8760-D435C3E1E729Q33354119-0AECE69E-63CC-4D78-A4EB-1328F73DF24BQ33598920-C69EC3D6-2092-4329-BEBC-1BA86898CE3AQ33623357-C4117BD9-1D55-46D3-882B-108A9F7FC05AQ33649031-F9EC1359-B7CA-458F-B301-1E41F9878EC3Q33689582-3705E247-D5A6-4426-897F-955934C79741Q33692555-D73F8D08-8B24-4EEA-AAC1-A839F90650C9Q33727536-72CFF5B1-2E9D-4566-8FFD-5D30C6BCFFDBQ33732309-86A7AE62-4FA6-458D-ABAD-CAEC84212430Q33733437-7C3F3BB4-EC3D-486A-AC39-35742C987AC3Q33754644-97ACBE9F-3ACF-40D6-9D66-4860390E5336Q33765731-F7F2A826-C734-46FC-9831-03DEA288C746Q33767262-7D8879EA-006C-4123-A287-0AEAC7FC54F3Q33775828-18034459-0C5A-4948-8C8D-DBBF5524E832
P2860
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@ast
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@en
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@nl
type
label
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@ast
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@en
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@nl
prefLabel
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@ast
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@en
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@nl
P3181
P1476
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
@en
P2093
C J Robinson
S E Stringer
P304
P3181
P407
P577
2001-03-01T00:00:00Z